The Role of Class II Molecules in Development of Insulin-Dependent Diabetes Mellitus in Mice, Rats and Humans
- 79 Downloads
The major histocompatibility complex (MHC) represents a genetic risk factor for most known autoimmune diseases. More and more evidence implicates the class II region of the MHC in susceptibility in diseases such as insulin-dependent diabetes mellitus (IDDM), rheumatoid arthritis, and pemphigus vulgaris (for review see TODD et al. 1988). The gene products of this region are highly polymorphic and each individual expresses one or two alleles at each locus. Their function is the regulation of the immune response by binding fragments of proteins (peptides) with many different sequences and presenting them to the T cell receptor (TCR) which is expressed by T lymphocytes. Due to the polymorphism of class II molecules, each molecule binds a specific set of peptides (BUUS et al. 1987). These molecules are selective, but relatively nonspecific peptide receptors expressed on B lymphocytes, macrophages, and other cells collectively termed antigen presenting cells (APC’c) (UNANUE and ALLEN 1987). T cells expressing the surface marker CD4 represent the predominant type of T cells which interact with class II expressing cells. After formation of the trimolecular complex between TCR, MHC class II antigen, and peptide, T cell proliferation and differentiation is initiated.
KeywordsMajor Histocompatibility Complex Major Histocompatibility Complex Class Experimental Allergic Encephalomyelitis Major Histocompatibility Complex Molecule Major Histocompatibility Complex Antigen
Unable to display preview. Download preview PDF.
- Acha-Orbea H, McDevitt HO (1986) The cDNA-sequence of the I-A major histocompatibility antigens of the non-obese diabetic mouse. In: Jaworsky MA, Molnar GD, Rajotte RV, Singh B (eds) Excerpta Medica international congress series: immunology of diabetes. Excerpta Medica, Amsterdam, pp 73–78Google Scholar
- Carnaud C, Bendelac A, Boitard C, Bach JF (1988) Failure to induce neonatal tolerance in the autoimmune nonobese diabetic (NOD) mouse strain. Diabetes 37: 1AGoogle Scholar
- Jacob CO, Aiso S, Michie SA, Mevitt HO, Acha-Orbea H (1990) Tumor necrosis factor in autoimmunity: protective effect on non-obese diabetic mice. Proc Natl Acad Sci US, in pressGoogle Scholar
- Moeller, G (ed) (1985) Molecular genetics of class I and II MHC antigens. Immunol Rev 84 and 85Google Scholar
- Naparstek Y, Baur K, Reis MD, Breitman L, Mak TW, Schwartz RS, Madaio MP (1988) Autoreactive T cells with a typical MHC restiction for MLR-lpr/lpr mice: forbidden clones revisited J Mol Cell Immunol 4: 35–43Google Scholar
- Parsitol HS, Hirsch RL, Haley AS, Johnson KP (1986) Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1: 893–894Google Scholar
- Segiescu D, Cerutti I, Efthymiou E, Kahan A, Chany C (1979) Adverse effects of interferon treatment on the life span of NZB mice. Biomed Exp 31: 48Google Scholar
- Wicker LS, Miller BJ (1988) The MHC-linked gene in the NOD mouse is not absolutely recessive. Diabetes 37: 10AGoogle Scholar
- Zinkernagel RM, Dohertly PC (1979) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction specificity, function and responsiveness. Adv Immunol 27: 52–177Google Scholar